FilingIndex
DEF 14AThe Ballot

IOVANCE BIOTHERAPEUTICS, INC. files DEF 14A

Filed Apr 20, 2017 · 9y ago · Accession 0001144204-17-021112

Plain English

Proxy statement — executive pay, board nominees, and shareholder votes.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
IOVA
CIK
1425205
Form type
DEF 14A
Filing date
Apr 20, 2017
Report date
Jun 1, 2017
Document
v464522_def14a.htm
Size
2.2 MB